Innoviva Inc is a biopharmaceutical company focused on the development and commercialization of medicines for various respiratory conditions. Its portfolio includes RELVAR/BREO ELLIPTA and ANORO ELLIPTA for chronic obstructive pulmonary disease and asthma, as well as treatments for high blood pressure in shock patients and complicated intra-abdominal infections. Innoviva also works on developing new treatments, such as a potential single-dose cure for gonorrhea. Originally named Theravance, the company rebranded to Innoviva in 2016 and is based in Burlingame, California.
If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital…
